Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Moodys
Fish and Richardson
US Department of Justice
QuintilesIMS
Fuji
Accenture
McKinsey
Daiichi Sankyo

Generated: January 16, 2018

DrugPatentWatch Database Preview

CEFOBID Drug Profile

« Back to Dashboard

Which patents cover Cefobid, and what generic alternatives are available?

Cefobid is a drug marketed by Pfizer and is included in three NDAs.

The generic ingredient in CEFOBID is cefoperazone sodium. There are four drug master file entries for this compound. Additional details are available on the cefoperazone sodium profile page.
Drug patent expirations by year for CEFOBID
Medical Subject Heading (MeSH) Categories for CEFOBID

US Patents and Regulatory Information for CEFOBID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CEFOBID cefoperazone sodium INJECTABLE;INJECTION 063333-001 Mar 31, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer CEFOBID IN PLASTIC CONTAINER cefoperazone sodium INJECTABLE;INJECTION 050613-001 Jul 23, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer CEFOBID cefoperazone sodium INJECTABLE;INJECTION 050551-002 Nov 18, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer CEFOBID cefoperazone sodium INJECTABLE;INJECTION 050551-001 Nov 18, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer CEFOBID cefoperazone sodium INJECTABLE;INJECTION 063333-002 Mar 31, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer CEFOBID IN PLASTIC CONTAINER cefoperazone sodium INJECTABLE;INJECTION 050613-002 Jul 31, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer CEFOBID cefoperazone sodium INJECTABLE;INJECTION 050551-003 Mar 5, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Deloitte
Chubb
Covington
QuintilesIMS
UBS
Accenture
Healthtrust
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot